Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been associated with increased occurrence of Fournier’s gangrene (FG), a rare but serious form of necrotizing fasciitis, leading to a warning from the Food and Drug Administration. Real-world evidence on FG is needed to validate thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jeff Yufeng, Wang, Tiansheng, Pate, Virginia, Buse, John B, Stürmer, Til
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039596/
https://www.ncbi.nlm.nih.gov/pubmed/31958306
http://dx.doi.org/10.1136/bmjdrc-2019-000985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039596/
https://www.ncbi.nlm.nih.gov/pubmed/31958306
http://dx.doi.org/10.1136/bmjdrc-2019-000985

Ejemplares similares